Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT02253368
Eligibility Criteria:
Inclusion Criteria:
* Age: 21-40 years
* Body mass index: 25.0 to 29.9 kg/m2
* Average habitual sleep duration of 6.5 hours or less per night (as confirmed by actigraphy)
* stable sleep habits for the past 6 months
Exclusion Criteria:
* obstructive sleep apnea or history of any other sleep disorder
* night or rotating shift work (current or in the past 2 years)
* habitual daytime naps
* recent (\< 4 week) travel across time zones
* extreme chronotypes
* any acute or chronic medical condition
* diabetes
* prior or current eating or psychiatric disorders
* claustrophobia
* irregular menstrual periods, menopause, pregnancy,
* alcohol abuse, excessive caffeine intake, smoking, illegal drug use
* subjects who are currently following a weight loss regimen or any other special diet or exercise programs
* subjects who have received iv or oral contrast in the past 2 weeks
* use of any prescription medication that can affect sleep or metabolism with the exception of antihypertensive and lipid lowering agents as follows. Subjects who are taking anti-hypertensive medication and/or lipid-lowering agents will be included only if they are well controlled and on a stable regimen (no change in medications in the previous 3 months). However, beta-blockers and thiazide diuretics will not be allowed, as these medications are known to affect insulin sensitivity. Women will be required to not be on hormone replacement therapy.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
40 Years
Study:
NCT02253368
Study Brief:
Protocol Section:
NCT02253368